Status:

RECRUITING

Restoring Iron Deficiency in POTS

Lead Sponsor:

Vanderbilt University Medical Center

Collaborating Sponsors:

Dysautonomia International

Conditions:

POTS - Postural Orthostatic Tachycardia Syndrome

Eligibility:

FEMALE

18-45 years

Phase:

PHASE2

Brief Summary

People with postural orthostatic tachycardia syndrome (POTS) often have low red blood cell volumes and low ferritin in their blood (a marker of iron storage in the body). The purpose of this pilot stu...

Detailed Description

This pilot study involves undergoing a physical exam and medical history, answering some questionnaires, and visiting the Vanderbilt Autonomic Dysfunction Center before and 2 months after the iron tre...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Age 18-45 years old.
  • Diagnosis of POTS, defined by a sustained heart rate increase of at least 30 bpm within 10 min of standing or head-up tilt (or absolute upright heart rate \>120 bpm), in the absence of orthostatic hypotension, and with at least 3 months of symptoms of orthostatic intolerance.
  • Absence of other diseases or medications that can explain orthostatic tachycardia or symptoms.
  • Serum ferritin \<50 ng/ml.
  • Patients on fludrocortisone will be allowed to participate as long as they have been on the same dose for at least one month before enrollment and continue on the same dose throughout the study.
  • Exclusion Criteria
  • Unable or unwilling to provide consent.
  • Pregnancy.
  • Being chair- or bed-ridden.
  • Unable to hold POTS medications during study procedures (i.e., autonomic testing).
  • History of active bleeding (other than menstruation).
  • History of hypersensitivity to any iron preparation of recent (within 6 months) treatment with any IV iron preparation.

Exclusion

    Key Trial Info

    Start Date :

    November 24 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2026

    Estimated Enrollment :

    12 Patients enrolled

    Trial Details

    Trial ID

    NCT07197905

    Start Date

    November 24 2025

    End Date

    December 1 2026

    Last Update

    December 11 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Autonomic Dysfunction Center/ Vanderbilt University Medical Center

    Nashville, Tennessee, United States, 37232